What is Kutapressin, and how is it related to Nexavir?

Kutapressin is the original name of the compound developed in the 1930s by Kremers Urban. Nexco Pharma acquired the rights to this same formulation in 2004 and rebranded it as Nexavir.

Is Nexavir FDA approved?

Nexavir holds FDA approval on a "grandfathered" basis, a designation given to formulations that predate current FDA testing protocols and have an established history of clinical use.

What is Nexavir made from?

Nexavir is a processed extract derived from porcine (pig) liver, yielding a mixture of small proteins known as polypeptides.

Is Nexavir safe to use?

Nexavir has a long-established safety profile built over 75 years of clinical use, with no significant safety concerns identified in that history. Individuals with pork allergies should not use Nexavir.

What are polypeptides, and why are they used in biologic medicine?

Polypeptides are short chains of amino acids found naturally in biological tissue. As a biologic compound rather than a synthetic one, they are of ongoing research interest for their potential anti-inflammatory and antiviral properties.

What is Nexco Pharma researching for the future?

Nexco Pharma's research teams are working to isolate and characterize Nexavir's active polypeptides, with the long-term goal of developing a scalable, non-biological synthetic alternative.

How is a "grandfathered" FDA drug different from a newly approved one?

A grandfathered drug predates the FDA's modern testing and approval protocols. Its regulatory standing is supported by decades of documented real-world clinical use rather than a single formal trial process.

Understanding Long COVID Fatigue vs. ME/CFS: Symptoms, Overlap, and Management

For millions of people worldwide, recovering from an acute viral infection doesn’t always mean returning to full health. Long after the initial virus has cleared, many individuals find themselves battling a complex web of debilitating symptoms—most notably persistent exhaustion, cognitive sluggishness, and unrefreshing sleep.

Two conditions at the center of this growing health crisis are Long COVID (post-acute sequelae of SARS-CoV-2) and Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). While one gained global attention during the pandemic and the other has been documented for decades, researchers and clinicians increasingly recognize that these conditions share deep biological, neurological, and immunological similarities.

Understanding the overlap between Long COVID fatigue and ME/CFS is crucial for patients seeking clarity, accurate diagnosis, and effective strategies for post viral fatigue syndrome management.

What Is Post-Viral Fatigue Syndrome?

Post-viral fatigue syndrome occurs when the body’s immune and nervous systems remain in a state of dysfunction or hyper-reactivity following a viral illness. Instead of returning to baseline homeostasis, the immune system stays perpetually activated or becomes dysregulated, triggering chronic systemic inflammation.

While viruses such as Epstein-Barr Virus (EBV), Human Herpesvirus 6 (HHV-6), and enteroviruses have historically been linked to ME/CFS, SARS-CoV-2 introduced a massive surge of post-viral cases across the globe.

Symptom Overlap: Long COVID vs. ME/CFS

When evaluating ME CFS symptoms alongside Long COVID, the clinical overlap is striking. Studies published in major medical journals suggest that a significant percentage of Long COVID patients actually meet the diagnostic criteria for ME/CFS.

Common shared symptoms include:

Post-Exertional Malaise (PEM): The hallmark symptom of both conditions. PEM is an overwhelming surge of fatigue and symptom worsening that occurs after even mild physical, mental, or emotional exertion.
Profound Chronic Fatigue: Unrelenting exhaustion that is not relieved by sleep or rest and severely limits daily activities.
Brain Fog & Cognitive Impairment: Difficulty concentrating, memory gaps, slow processing speed, and word-finding difficulties.
Orthostatic Intolerance & POTS: Dizziness, rapid heart rate, or lightheadedness when moving from a lying or sitting position to standing.
Unrefreshing Sleep: Waking up feeling just as tired as before going to bed, often accompanied by disrupted sleep architecture.
Immune & Dysautonomia Dysfunctions: Recurrent low-grade fever, sore throat, swollen lymph nodes, and sensitivity to light, sound, or temperature.

Biological Markers: What Is Happening Inside the Body?

Researchers studying the pathophysiology of post-viral fatigue syndromes have identified several shared biological abnormalities between Long COVID and ME/CFS:

Persistent Microvascular & Endothelial Dysfunction: Both conditions often exhibit microclots and impaired vascular function, reducing oxygen delivery to tissues and brain regions.
Mitochondrial & Metabolic Dysfunction: Cellular powerhouses (mitochondria) fail to produce energy efficiently, leading to rapid muscle exhaustion and metabolic crash after physical activity.
Chronic Neuroinflammation: Brain imaging in both patient populations frequently shows elevated microglial activation, explaining persistent brain fog, mood fluctuations, and central nervous system fatigue.
Viral Persistence & Latent Reactivation: In many cases, viral fragments remain trapped in tissue reservoirs, or initial viral stress causes latent viruses (like EBV) to reactivate and continuously stimulate the immune system.

Strategies for Post-Viral Fatigue Syndrome Management

Because post-viral illness affects multiple body systems, management typically requires an individualized, multi-pronged approach under professional guidance.

1. Activity Management & Pacing

Pacing is the foundation of energy management. By learning to stay within your "energy envelope," patients can avoid the dangerous push-and-crash cycle associated with Post-Exertional Malaise. Utilizing heart rate monitoring and keeping daily symptom logs can help identify baseline limits.

2. Supportive Immune & Symptom Therapies

Managing autonomic dysfunction (such as increasing fluid and salt intake for POTS under medical direction) and treating sleep disturbances can significantly improve quality of life.

3. Targeted Topical & Therapeutic Options

In the search for effective Long Covid fatigue treatment and fatigue management protocols, researchers and integrative clinicians have looked toward specialized compounds aimed at reducing systemic inflammation and supporting tissue recovery.

One noteworthy historic and emerging area of interest is porcine liver extract for chronic fatigue. Polypeptide mixtures derived from liver tissue—originally utilized in anti-inflammatory dermatological and immune formulations—have a long clinical history of use in post-viral protocols. Non-prescription formulations such as Nexco Cream 75, which features standardized porcine liver extract, are frequently incorporated by individuals seeking targeted topical relief for unspecified viral symptoms, localized inflammation, and chronic fatigue discomfort.

Key Benefits of Nexco Cream 75 in Managing Long COVID Fatigue:

Topical Anti-Inflammatory Action: Utilizes a purified porcine liver extract rich in natural polypeptides to help resolve micro-vascular inflammation and swelling associated with persistent post-viral immune activation.
Targeted Fatigue & Brain Fog Relief: Temporarily alleviates systemic exhaustion, cognitive sluggishness, and fatigue symptoms triggered by post-viral sequelae.
Non-Prescription & Non-Invasive: Offers an easily accessible, non-prescription topical alternative to clinical injections for individuals seeking non-invasive ongoing support.
Support for Persistent Viral Symptoms: Formulated to assist with overlapping symptoms common in Long COVID, ME/CFS, and reactivated viral conditions (such as EBV or HHV-6).
Established Safety Profile: Leverages active ingredients derived from a 75-year legacy of clinical use (tracing back to historic Kutapressin formulations) with a well-documented history of safety.

The Road Ahead

Living with post-viral fatigue or ME/CFS can feel isolating, but scientific research is accelerating faster than ever before. As global awareness grows, the shared mechanisms between Long COVID and ME/CFS are unlocking new insights into targeted interventions, diagnostic biomarkers, and restorative care.

Frequently Asked Questions (FAQs)

Q1: How does Long COVID fatigue differ from standard everyday tiredness?

Answer: Unlike standard tiredness—which improves with adequate sleep and relaxation—Long COVID fatigue is chronic, profound, and often accompanied by Post-Exertional Malaise (PEM). A "crash" in energy can occur hours or days after minimal physical or cognitive effort, accompanied by symptoms like brain fog, low-grade inflammation, and autonomic dysfunction.

Q2: Why do Long COVID and ME/CFS share so many identical symptoms?

Answer: Both conditions share similar underlying biological pathways. Research indicates that both Long COVID and ME/CFS involve persistent neuroinflammation, micro-vascular dysfunction, cellular energy failure (mitochondrial dysfunction), and dysregulated immune responses triggered by an initial viral threat.

Q3: What is Nexco Cream 75, and how does it support post-viral recovery?

Answer: Nexco Cream 75 is a non-prescription topical formulation containing active herbal extracts and porcine liver extract (rich in natural polypeptides). It is used to help manage systemic inflammation, localized pain, and persistent fatigue discomfort associated with post-viral conditions.

Q4: Is Nexco Cream 75 the same as Nexavir Injectable?

Answer: While both products utilize the biological benefits of porcine liver extract (derived from the historic Kutapressin lineage), Nexavir is a prescription-based injectable drug. Nexco Cream 75 is a convenient, non-invasive, topical alternative available without a prescription for everyday fatigue management protocols.

For information about the Nexco Cream 75, visit our webpage: https://www.nexco-pharma.com/products/nexco-cream-75

For information about the Nexavir Injectable, visit our webpage: https://www.nexco-pharma.com/products/nexco-cream-75